Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 2, 1998, Pages 215-223

  Francis, Sheila E ^a   Holden, Hazel ^b   Holt, Cathy M ^a   Duff, Gordon W ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cardiomyopathy; Cytokines; Inflammation; Interleukin 1

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PLATELET DERIVED GROWTH FACTOR A; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; CELL TYPE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; FEMALE; GENETIC PREDISPOSITION; HEART FAILURE; HEART MUSCLE; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; INFECTION; INFLAMMATION; INJURY; ISCHEMIC HEART DISEASE; MACROPHAGE; MALE; MEDIATOR; MUSCLE CELL; MUSCLE CONTRACTILITY; NORTHERN BLOTTING; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VIRUS INFECTION;

EID: 0032005821     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0592     Document Type: Article

References (31)

1. BAGASRA O, POMERANTZ RJ, 1992. Detection of HIV provirus by in situ PCR. New Engl J Med 327: 1530.
2. BALLIGAND JC, UNGUREANU-LONGROIS D, SIMMONS WW, PIMENTAL P, MALINSKA TA, KAPTURCZAK M, TAHA K, LOWENSTEIN CJ, DAVIDOFF AJ, KELLY RA, SMITH TW, MICHEL T, 1994. Cytokine-inducible Nitric Oxide Synthase (iNOS) expression in Cardiac Myocytes. J Biol Chem 269: 27580-27588.
3. CHOMYNCZSKI P, SACCHI N, 1977. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem 62: 156-159.
4. DE BELDER AJ, RADOMSKI MW, WHY HJF, RICHARDSON PJ, BUCKNALL CA, SALAS E, MARTIN JF, MONCADA S, 1993. Nitric oxide synthase activities in human myocardium. Lancet 341: 84-85.
5. DI GIOVINE FS, DUFF GW, 1990. Interleukin 1: the first interleukin. Immunology Today 11: 13-20.
6. DI GIOVINE F, SYMONS JA, DUFF GW, 1991. Kinetics of IL-1beta mRNA and protein accumulation in human mononuclear cells. Immunol Lett 29: 211-218.
7. DINARELLO CA, 1993. Modalities for reducing Interleukin-1 acitivity in disease. Trends Pharmacol Sci 14: 155-159.
8. DUFF GW, 1989. Peptide regulatory growth factors in non-malignant disease. Lancet 8652: 1432-1435.
9. FENOGLIO JJ, URSELL PC, KELLOGG CF, DRUSIN RE, WEISS MB, 1983. Diagnosis and classification of myocarditis by endomyocardial biopsy. N Engl J Med 308: 12-18.
10. FINKEL MS, ODDIS CV, JACOB TD, WATKINS SC, HATTLER BG, SIMMONS RL, 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-388.
11. FRANCIS SE, DUFF GW, 1993. p7B6, a ubiquitous mRNA with homology to the ribosomal RNA L41. Nucleic Acids Res 21: 2944-2945.
12. GLAUSER MP, ZANETTI G, BAUMGAMGARTNER JD, COHEN J, 1991. Septic shock: pathogenesis. Lancet 338: 732-736.
13. GOTTLOB R, 1977. The preservation of venous endothelium by dissection without touching by an atraumatic technique of vascular anastomosis. Minerva Chir 32: 693-700.
14. GULICK T, CHUNG MK, PIEPER SJ, LANGE LG, SCHREINER GF, 1989. Interleukin-1 and Tumour necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci 86: 6753-6757.
15. HAJJAR P, 1991. Viral pathogenesis of atherosclerosis. Am J Pathol 139: 1195-1211.
16. HAN RO, RAY PE, BAUGHMAN KL, FELDMANN AM, 1991. Detection of interleukin and interleukin receptor mRNA in human heart by PCR. Biochem Biophys Res Commun 181: 520-523.
17. HUNNINGHAKE GW, MONKS BG, GEIST LJ, MONICK MM, MONROY MA, STINSKI MF, WEBB AC, DAYER J-M, AURON PE, FENTON MJ, 1992. The functional importance of a cap site-proximal region of the human prointerleukin 1β gene is defined by viral protein trans-activation. Mol Cell Biol 12: 3439-3448.
18. JOULOU-SCHAEFFER G, GRAY GA, FLEMING I, SCHOTT C, PARRATT JR, STOCLET J-C, 1990. Loss of vascular responsiveness induced by endotoxin involves the L-arginine pathway. Am J Physiol 259: H1038-H1043.
19. KUHL U, NOUTSIAS M, SEEBERG B, SCHULTHEISS H-P, 1996. Immunohistochemical evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 75: 295-300.
20. LANGE LG, SCHREINER GF, 1992. Immune mechanisms of cardiac disease. N Engl J Med 330: 1129-1135.
21. LIBBY P, WARNER SJ, FRIEDMAN GB, 1988. Interleukin-1 a mitogen for human vascular smooth muscle cells that induces the release of growth inhibitory prostanoids. J Clin Invest 81: 487-498.
22. MARRIOTT JB, GOLDMAN JH, KEELING PJ, BAIG MK, DALGLEISH AG, MCKENNA WJ, 1996. Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives. Heart 75: 287-290.
23. MATSUMORI A, YAMADA T, SUZUKI H, MATOBA Y, SASAYAMA S, 1994. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 72: 561-566.
24. MAYER CF, SAJUTHI D, TULLI H, WILLIAMS JK, 1991. Synthesis of IL-1α and IL-1β by arterial cells in atherosclerosis. Am J Pathol 138: 151-160.
25. Ross R, 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
26. SCHINDLER R, GHEZZI P, DINARELLO CA, 1990a. IL-1 induces IL-1. J Immunol 144: 2216-2222.
27. SCHINDLER R, CLARK BD, DINARELLO CA, 1990b. Dissociation between IL-1β mRNA and protein synthesis in human peripheral blood mononuclear cells. J Biol Chem 265: 10232-10237.
28. SHAH AM, EVANS HG, LEWIS MJ, 1992. IL-1β mimics the characteristic effect of endothelium-derived relaxing factor (EDRF) on myocardial contraction. (Abstract) J Vasc Res 29: 195.
29. SMITH SC, ALLEN PM, 1992. Neutralisation of endogenous tumour necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ Res 70: 856-863.
30. WOODRUFF JF, 1980. Viral myocarditis: a review. Am J Pathol 101: 426-479.
31. YANAGUCHI M, DU W, GOULD KE, DIFFENBACH CW, CRUESS DF, SHAREKIN JB, 1991. Effects of aspirin, dipyramidole and dibutyryl cyclic adenosine monophosphate on PDGF A chain mRNA levels in human saphenous vein endothelial cells and smooth muscle cells. Surgery 110: 377-384.